Rogy reda

Dr. Rogy reda

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
AGAhmed A. Gaber
Ahmed A. Gaber
AEAhmed M. El‐Morsy
Ahmed M. El‐Morsy
FSFarag F. Sherbiny
Farag F. Sherbiny
ABAshraf H. Bayoumi
Ashraf H. Bayoumi
KEKamal M. El‐Gamal
Kamal M. El‐Gamal
Hamada S. AbulkhairHamada S. Abulkhair
Hamada S. Abulkhair

12 April 2022 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
RRRogy reda
Rogy reda
Ahmed A. Al-KarmalawyAhmed A. Al-Karmalawy
Ahmed A. Al-Karmalawy
MAMohammad Hayal Alotaibi
Mohammad Hayal Alotaibi
MSMarwa A. Saleh
Marwa A. Saleh
Different mechanisms of action for the quinoxaline moiety to fight breast cancer.

26 May 2021 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
MSMarwa A. Saleh
Marwa A. Saleh
MEMohamed A. El‐Badry
Mohamed A. El‐Badry
RRRogy reda
Rogy reda

4 September 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RRRogy reda
Rogy reda
MSMarwa A. Saleh
Marwa A. Saleh
SASefat A. Alwarsh
Sefat A. Alwarsh
ARAreej Rushdi
Areej Rushdi
AAAzza Ali Althoqapy
Azza Ali Althoqapy
AMAyman Mohamed
Ayman Mohamed
Herein, a series of new isatin derivatives was designed and synthesized (1–9) as broad-spectrum antiviral agents. Consequently, the antiviral activities of the synthesized compounds (1–9) were pursued against three viruses, namely influenza virus (H1N1), herpes simplex virus 1 (HSV-1), and coxsackievirus B3 (COX-B3). In particular, compounds 9, 5, and 4 displayed the highest antiviral activity against H1N1, HSV-1, and COX-B3 with IC50 values of 0.0027, 0.0022, and 0.0092 µM, respectively. Compound 7 was the safest, with a CC50 value of 315,578.68 µM. Moreover, a quantitative PCR (real-time PCR) assay was carried out for the most relevant compounds. The selected compounds exhibited a decrease in viral gene expression. Additionally, the conducted in silico studies emphasized the binding affinities of the synthesized compounds and their reliable pharmacokinetic properties as well. Finally, a structure–antiviral activity relationship study was conducted to anticipate the antiviral activity change upon future structural modification.

5 October 2022 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MSMarwa A. Saleh
Marwa A. Saleh
AMAyman Mohamed
Ayman Mohamed
HSHoda S. El Saeed
Hoda S. El Saeed
MSMoustafa M. Saleh
Moustafa M. Saleh
MSMohammed Salah
Mohammed Salah
RRRogy reda
Rogy reda

7 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RRRogy reda
Rogy reda
MSMarwa A. Saleh
Marwa A. Saleh
SASefat A. Alwarsh
Sefat A. Alwarsh
ARAreej Rushdi
Areej Rushdi
AAAzza Ali Althoqapy
Azza Ali Althoqapy
AMAyman Mohamed
Ayman Mohamed
The Pharmaceuticals Editorial Office retracts the article “Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies”